News
Merck's Pediatric Vaqta Returns - 11/14/2008
Merck will begin receiving and processing orders for PEDIATRIC Vaqta December 1, 2008. Contract members will return to purchasing the Hep A/ Vaqta from Merck. The return of Vaqta will mean that the limited special offer of an additional 3% off MMR, Varivax, Recombivax and Pneumovax will cease December 1, 2008. We are encouraging practices to check their inventories and order accordingly.
FDA Approves Pentacel® - 9/1/2008
The approval by the FDA of sanofi pasteur’s Pentacel® is causing a number of practices to rethink how they will administer the Recommended Immunization Schedule for Persons Aged 0-6 years, 2008. Due to a large number of requests at the CPP office, we are sending out to all group purchase participants a version of how to administer the vaccine schedule utilizing Pentacel® while also remaining eligible for maximum CPP vaccine discounts. A practice following this version of the schedule achieves the lowest cost, fewest shot approach during the vaccine intensive first 24 months.
New Vaccine Awareness Website for Parents - 8/12/2008
A website awareness campaign has been developed to educate parents regarding immunizations and how to protect children from vaccine preventable diseases. The website www.vaccinateyourbaby.org has scientific information that can be reviewed by parents who are interested in learning more about the safety of vaccines. Information from the AAP, AMA, CDC and several other prominent health care advocacy organizations can be found on the website.
CDC Hib Recommendation - 1/1/2008
The recommended vaccination schedule for all available Hib-containing vaccines consists of a primary series (consisting of 2 or 3 doses, depending on the formulation) administered beginning at age 2 months and a booster dose at age 12–15 months. Because of the short-term reduction in available doses of Hib-containing vaccines, CDC recommends that providers temporarily defer administering the routine Hib vaccine booster dose given at age 12–15 months except for children in specific groups at higher risk. Please visit www.cdc.gov/vaccines/recs/recalls/hib-recall-faqs-12-12-07.htm for more information. CDC is also asking providers to order only the number of doses of vaccine required to meet immediate needs (i.e., a supply for up to 4 weeks) and to refrain from attempting to build an inventory of Hib vaccine.
|
